1. Home
  2. Labeler Index
  3. Srini Pharmaceuticals Private Limited
  4. 66174-0087
  5. NDC Package Code: 66174-0087-0 Rivaroxaban

NDC Package 66174-0087-0 Rivaroxaban

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
66174-0087-0
Package Description:
50 kg in 1 DRUM
Product Code:
66174-0087
Non-Proprietary Name:
Rivaroxaban
Substance Name:
Rivaroxaban
Usage Information:
Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.
11-Digit NDC Billing Format:
66174008700
Product Type:
Bulk Ingredient
Labeler Name:
Srini Pharmaceuticals Private Limited
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
  • RIVAROXABAN 1 kg/kg
    • Sample Package:
    N/A
    Marketing Category:
    BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
    Start Marketing Date:
    11-22-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 66174-0087-0?

    The NDC Packaged Code 66174-0087-0 is assigned to an UNFINISHED drug package of 50 kg in 1 drum of Rivaroxaban, a bulk ingredient labeled by Srini Pharmaceuticals Private Limited. The product's dosage form is powder and is administered via form.

    Is NDC 66174-0087 included in the NDC Directory?

    Yes, Rivaroxaban is an UNFINISHED PRODUCT with code 66174-0087 that is active and included in the NDC Directory. The product was first marketed by Srini Pharmaceuticals Private Limited on November 22, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 66174-0087-0?

    The 11-digit format is 66174008700. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-166174-0087-05-4-266174-0087-00